CAS#:2381089-84-3
Survodutide
Size
Research Profile
Survodutide
Literature-based research context for laboratory reference only.
Survodutide (BI 456906) is a dual glucagon/GLP-1 receptor agonist. Research examines its ability to harness glucagon's lipolytic effects alongside GLP-1-mediated insulin secretion, exploring applications in obesity and metabolic liver disease.
Selected literature
- Funakoshi et al., 2024, New England Journal of Medicine.
This page is provided for laboratory reference and literature review only. The material is not presented as a consumer product, medical treatment, diagnostic tool, or recommendation for human or animal use.
Overview
Survodutide is presented here as a laboratory reference entry. The Research Profile summarizes literature-based biological context, while this Overview documents the identity record, specification set, preparation format, and quality-reference information available on the page.
The identity block lists CAS number 2381089-84-3, molecular formula C₁₇₈H₂₇₉N₅₁O₆₀, and molecular weight 4,041.5 Da. The material record is paired with ≥99% purity information and a lyophilized presentation for reference review.
Available specification labels include 2mg, 5mg, and 10mg. The active selection is 2mg; changing the selector updates the visible specification label and COA lot references while preserving the same research-reference context.
For the active selection, the page currently shows 1 active COA lot reference. COA links, when present, are retained for batch-level purity, identity, and quantity review, while packaging and storage details remain separated in Structure & Identity.